The ability of three psychrotrophic Gram-negative bacilli isolated from Chilean Patagonian cold freshwater rivers to produce bioactive metabolites was evaluated. The strains were isolated from cold waters rivers and identified by their biochemical properties and 16S rRNA gene analysis. The metabolites fractions showing antibacterial activity were obtained by solvent extraction and partially characterized by gas-mass chromatography (GC-MS). Antibacterial activity of the fractions was evaluated by an agar-well diffusion test upon 14 bacterial strains, both Gram positive and Gram negative. Thermal and proteolytic resistances of the antibacterial metabolites fractions were also evaluated. Molecular analysis allows the identification of the three Patagonian strains as Pseudomonas sp. RG-6 (Pseudomonas brenneri 99.6 % identity), Pseudomonas sp. RG-8 (Pseudomonas trivialis 99.6 % identity) and Yersinia sp. RP-3 (Yersinia aldovae 99.5 % identity). These extracts were able to inhibit both Gram-positive and Gram-negative bacteria but not Listeria monocytogenes. The antibacterial activity of the filtrated supernatants was lost at temperatures ≥60 °C, and was not affected by proteinase K treatment. The chemical structure of the active molecule remains to be elucidated, although the GC-MS analysis of the filtrates suggests that compounds like sesquiterpenes derivatives from β-maaliene or δ-selinene could be responsible of this antibacterial activity. Pristine cold freshwater streams showed to be interesting sources of metabolites-producing microorganisms with antibacterial activity.

Laboratorio de Microbiología Básica y Biorremediación Departamento de Microbiología Universidad de Concepción Casilla Concepción Chile

Zobrazit více v PubMed

Curr Med Chem. 2001 May;8(6):583-606 PubMed

J Basic Microbiol. 2007 Dec;47(6):496-505 PubMed

Appl Environ Microbiol. 1987 Dec;53(12):2957-62 PubMed

J Biosci Bioeng. 2004;98(5):317-30 PubMed

Annu Rev Microbiol. 2002;56:117-37 PubMed

Antimicrob Agents Chemother. 2003 Jul;47(7):2113-7 PubMed

Cell Mol Life Sci. 2004 Jun;61(12):1401-26 PubMed

Microb Ecol. 1988 Sep;16(2):115-31 PubMed

Nat Prod Rep. 1999 Oct;16(5):565-74 PubMed

Nucleic Acids Res. 1997 Sep 1;25(17):3389-402 PubMed

Appl Microbiol Biotechnol. 2007 Jul;75(6):1377-84 PubMed

Clin Microbiol Infect. 2004 Nov;10 Suppl 4:10-7 PubMed

Nucleic Acids Res. 1991 Jul 25;19(14):4008 PubMed

PLoS Genet. 2011 Feb;7(2):e1001314 PubMed

J Bacteriol. 1991 Jan;173(2):697-703 PubMed

Appl Environ Microbiol. 2007 Aug;73(16):5261-7 PubMed

J Nat Prod. 2009 Jan;72(1):99-101 PubMed

Mol Biol Evol. 1987 Jul;4(4):406-25 PubMed

Mol Biol Evol. 2007 Aug;24(8):1596-9 PubMed

Chem Biodivers. 2008 Oct;5(10):2113-23 PubMed

Mar Drugs. 2010 Mar 17;8(3):705-27 PubMed

Indian J Exp Biol. 2009 Dec;47(12):964-8 PubMed

Antonie Van Leeuwenhoek. 1971;37(1):51-63 PubMed

J Bacteriol. 2008 Sep;190(18):6084-96 PubMed

Appl Environ Microbiol. 2003 Jun;69(6):3500-9 PubMed

Nucleic Acids Res. 1997 Dec 15;25(24):4876-82 PubMed

Appl Environ Microbiol. 2001 Nov;67(11):4975-83 PubMed

J Clin Microbiol. 2003 Apr;41(4):1785-7 PubMed

Pseudomonas rossensis sp. nov., a novel psychrotolerant species produces antimicrobial agents targeting resistant clinical isolates of Pseudomonas aeruginosa